Check point inhibitors
Showing 1 - 25 of >10,000
Adverse Events in Patients Treated With Immune Check Point
Recruiting
- Immune-related Adverse Event
- Antiinflammatory/DMARDs
-
Kristiansand, Norway
- +4 more
Sep 15, 2022
Advanced Solid Tumor, Stereotactic Body Radiotherapy, Immune Checkpoint Inhibitor Trial in Peking (Cadonilimab, Stereotactic
Not yet recruiting
- Advanced Solid Tumor
- +4 more
- Cadonilimab
- Stereotactic body radiotherapy
-
Peking, Beijing, ChinaDepartment of radiation oncology, Peking University Third Hospit
Jun 20, 2023
Physical Activity and Exercise in Cancer Immunotherapy Treatment
Not yet recruiting
- Cancer
- Physical Activity and Exercise in Cancer Immunotherapy Treatment - Exploratory study of experiences and perceptions
- (no location specified)
Nov 22, 2023
CaboCHECK - Cabozantinib in Adult Advanced Renal Cell Carcinoma
Terminated
- Advanced Renal Cell Carcinoma (All Subtypes)
- Metastatic Renal Cell Carcinoma (All Subtypes)
- Documentation
-
Essen, Nordrhein-Westfalen, Germany
- +1 more
Dec 21, 2022
Point of Care Device to Measure HbA1c
Not yet recruiting
- Pregnant
- Postpartum
- Point of care device to measure HbA1c
- (no location specified)
Feb 10, 2023
Acral Melanoma, Mucosal Melanoma Trial in Seoul (Pembrolizumab, Vactosertib)
Not yet recruiting
- Acral Melanoma
- Mucosal Melanoma
- Pembrolizumab, Vactosertib
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Jun 23, 2022
Metastatic Renal Cell Carcinoma, Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score Trial in France
Not yet recruiting
- Metastatic Renal Cell Carcinoma
- Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score
- Combination PD-1/PD-L1 ICI + VEGFR-TKI
- Treatment pause
-
Bayonne, France
- +24 more
Aug 10, 2022
Multiple Myeloma, Lymphoma Trial in Washington, Hackensack (Ipilimumab, Nivolumab)
Active, not recruiting
- Multiple Myeloma
- Lymphoma
-
Washington, District of Columbia
- +1 more
Dec 2, 2021
The Status of Immune Checkpoints at Gastrointestinal Cancer
Completed
- Gastrointestinal Cancer
- Flow cytometric analysis
-
Istanbul, TurkeyIstanbul Training and Reseach Hospital
Dec 4, 2022
Sarcoma, Sarcoma,Soft Tissue, Sarcoma of Bone Trial in Shanghai (Camrelizumab and fluzoparib with concurrent stereotactic body
Recruiting
- Sarcoma
- +2 more
- Camrelizumab and fluzoparib with concurrent stereotactic body radiotherapy (SBRT)
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University, School of Medici
Oct 3, 2023
Head and Neck Squamous Cell Carcinoma, Skin Cancer, Metastatic Head-and-neck Squamous-cell Carcinoma Trial in Jerusalem
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +2 more
- Diffusing Alpha Radiation Emitters Therapy (DaRT)
- Pembrolizumab
-
Jerusalem, IsraelSharett institute, Hadassah University Hospital - Ein-Kerem
Nov 8, 2021
Breast Cancer, Metastatic Breast Cancer, Breast Tumor Trial in Port Jefferson Station (SV-BR-1-GM, Cyclophosphamide, Interferon
Not yet recruiting
- Breast Cancer
- +4 more
- SV-BR-1-GM
- +4 more
-
Port Jefferson Station, New YorkNew York Cancers & Blood Specialists
Oct 2, 2023
Locally Advanced Head Neck Cancer Trial in Kuwait (Pembrolizumab)
Recruiting
- Locally Advanced Head and Neck Cancer
-
Kuwait, KuwaitKuwait Cancer Control Center
Apr 13, 2021
Squamous Cell Head and Neck Carcinoma Trial (Durvalumab, radiotherapy, Placebo)
Withdrawn
- Squamous Cell Head and Neck Carcinoma
- Durvalumab
- +3 more
- (no location specified)
May 6, 2021
Breast Cancer, Hematologic Malignancy, Immune Checkpoint Inhibitor-Related Myocarditis Trial in Weston (anonymized data
Recruiting
- Breast Cancer
- +4 more
- anonymized data collection during programmed surveillance clinical follow up
-
Weston, FloridaCleveland Clinic Florida
Oct 27, 2022
Advanced Cancer, Cervical Cancer, Triple Negative Breast Cancer Trial in Sutton (ASTX660, Pembrolizumab)
Recruiting
- Advanced Cancer
- +2 more
-
Sutton, United KingdomRoyal Marden NHS Foundation Trust
May 25, 2022
Adrenocortical Carcinoma, Pheochromocytoma, Paraganglioma Trial in Worldwide (EO2401)
Recruiting
- Adrenocortical Carcinoma
- +2 more
- EO2401
-
Houston, Texas
- +9 more
Dec 7, 2021
Locally Advanced/Metastatic Solid Tumors Trial in Newport Beach, San Diego, Canton (FL115)
Active, not recruiting
- Locally Advanced/Metastatic Solid Tumors
-
Newport Beach, California
- +2 more
Nov 10, 2023
Glioblastoma, Adult Trial in Worldwide (Multiple dose of EO2401)
Recruiting
- Glioblastoma, Adult
- Multiple dose of EO2401
-
Boston, Massachusetts
- +9 more
Dec 7, 2021
Using Ex Vivo Tumoroids To Predict Immunotherapy Response In
Recruiting
- Lung Cancer
- +2 more
- Standard of care immune checkpoint inhbitors
-
Fairway, Kansas
- +1 more
Sep 19, 2022
Acute Kidney Injury Trial in Birmingham, Lexington, Nashville (Medication reconciliation, Blood Pressure Management)
Active, not recruiting
- Acute Kidney Injury
- Medication reconciliation
- Blood Pressure Management
-
Birmingham, Alabama
- +2 more
Dec 28, 2022
Prospective Clinical Cohort Study of Depression
Not yet recruiting
- Major Depressive Disorder
- selective serotonin reuptake inhibitors
- TMS
- (no location specified)
Mar 7, 2023
Immune Checkpoint Inhibitors Nephrotoxicity
Recruiting
- Kidney Injury
- Antineoplastics Toxicity
- Early kidney damage biomarkers
- Predisposition to kidney injury biomarkers
-
Salamanca, Spain
- +1 more
Jul 26, 2022
Pathways to Mitigate Immune-Related Adverse Events With Cancer
Recruiting
- Cancer
- systemic corticosteroid or biologic
-
Denver, Colorado
- +1 more
Sep 8, 2021
Surgical Wound, Post Operative Pain Trial in Belgrade (Etoricoxib 90 Mg Oral Tablet, Dexamethasone 4mg)
Completed
- Surgical Wound
- Post Operative Pain
- Etoricoxib 90 Mg Oral Tablet
- Dexamethasone 4mg
-
Belgrade, SerbiaSchool of Dental medicine, University of Belgrade
Mar 28, 2023